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MYOSIN 10 IS REQUIRED FOR SPINAL MOTOR AXON GROWTH AND GUIDANCE 
IN ZEBRAFISH EMBRYOS 
by 
CRYSTAL IVEY  
Under the Direction of Vinoth Sittaramane 
ABSTRACT 
Neurodevelopmental disorders are disabilities caused by malfunctioning 
mechanisms within the developing nervous tissue. These abnormalities often result in 
conditions such as autism spectrum disorders, Attention Deficient Hyperactivity 
Disorder (ADHD), motor dysfunctions, learning disabilities and mental retardation. 
Recent surveys indicate that there will be a 12% increase of children in the United States 
alone who are affected by neurodevelopmental disorders. Thus, it is important to 
understand both the normal and abnormal mechanisms of neural development. Neural 
development involves specification of new neurons and formation of neural circuits that 
connect the nervous system to every organ of the developing embryo. Neural circuits are 
formed by extensions of neuronal cell bodies called axons. Axons grow towards their 
specific target organs at growth cones, by sensing the environment for molecular cues 
which reorganizes their cytoskeleton to allow for their growth. Growth cones are actin 
rich suggesting that actin binding molecules play a vital role in axon guidance. Myosins 
are a class of actin binding proteins. Myosin 10 (myo10) is a myosin that is highly 
localized in growth cones indicating their potential role in axon guidance and growth. 
While myo10 has been shown to be involved in axon guidance in neural cell cultures, 
this has not been demonstrated in vivo. This aim of this project was to identify the roles 
of myo10 in axon growth cone guidance in vivo utilizing a zebrafish (Danio rerio) 
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model. I established that myo10 is required for spinal motor and hindbrain axon 
development in the zebrafish. In the absence of myo10, 100% of caudal primary motor 
neurons were defective and 88% of middle primary motor axons were defective. 
Additionally, I characterized the phenotype of myo10 deficient embryos further by 
examining the points of innervation of the motor axons. Spinal motor axons innervate 
the muscle. The post-synaptic muscle is lined with acetylcholine receptors. Myo10 
deficient embryos have a defective patterning of acetylcholine receptors and the muscles 
show indications of atrophy. Lastly, I provide some evidence for possible mechanisms in 
which myo10 may be functioning. 
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CHAPTER 1 
INTRODUCTION 
Purpose and Importance of the Study 
This study aims to understand the roles myo10, a 
potential axon guidance molecule, plays in the process 
of neurodevelopment. Neurodevelopment is a critical 
process during embryogenesis that gives rise to the 
nervous system. In all vertebrates, the nervous system 
consists of the brain, spinal cord, and the nerves that 
exit the spinal cord and make synapses with various 
structures throughout the body. The schematic in Figure 
1 displays the brain and the spinal cord in green and the 
spinal nerves that exit the spinal cord in blue. The cell 
body of each nerve is located in the spinal cord or brain 
and has a long protrution called an axon. During development, the axon of each cell 
body extends and projects away from the spinal cord to synapse with a specific 
collection of target cells. However, molecular deficits can lead to a failure of axons to 
migrate appropriately and fail to synapse with their targets (Ehninger et al 2008). 
Depending on the nature of the molecular deficiency, this can lead to a wide array of 
neurodevelopment disorders that can range from mild to fatal. Common conditions that 
are the result of these neurodevelopment disorders are autism spectrum disorders, 
ADHD, motor dysfunctions, learning disabilities, and mental retardation. Recent 
surveys indicate that neurodevelopment disorders are predicted to increase 12% by the 
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year 2030 (WHO, 2007). These disorders have many possible causes such as nutritional 
deficiencies, injuries, exposure to toxins, maternal causes, and genetics. Susceptibility to 
neurodevelopmental disorders typically increase with age. As medical advances have 
been made over the past century, the life expectancy is on the rise. Thus, 
neurodevelopmental disorders are drastically increasing (Brown et al. 2005). These 
disorders have a huge impact on not only the patient, but also society as a whole. The 
overall economic cost of neurodevelopmental disorders in the United States is estimated 
to be $81.5–167 billion dollars per year (Szpir, 2006). Thus, it is important to 
understand both the normal and abnormal mechanisms of neural development. Some 
studies have used cultured cells to study axon guidance molecules in vitro (Yu et al. 
2012). However, in vivo experimentation will give more insight on how proteins 
function in living systems. Others have demonstrated the use of model organisms such 
as frog,rat, mouse, chick, and fish to uncover the genetic abnormalities that cause 
neurodevelopment disorders in humans. For example, X.J. Zhu et al. 2007 used rats as 
model organisms to reveal that myo10 has a role in axon path-finding. However, 
zebrafish have recently become a widely used tool in neurodevelopment research. 
Zebrafish have many attractive properties for research. Firstly, 70% of human genes 
have at least one zebrafish orthologue (Howe et al. 2013). Also, the reproductive 
capability of zebrafish is impressive. They can lay 150-200 embryos per week. This 
allows ample opportunity for experimentation. Additionally, the embryos are fertilized 
externally allowing for easy embryo collection and manipulation. Also, the embryos are 
transparent. This enables the use of protocols such as whole mount in situ and antibody 
labeling. Furthermore, the embryos undergo complete embryogenesis within 3 days 
making data collection very quick in comparison to other models. Finally, there is a 
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plethora of information already known about zebrafish. Their genome has been 
sequenced and many studies have already utilized zebrafish resulting in databases of 
information and optimized techniques. 
Because other studies have demonstrated that myo10 defects result in decreased 
neurite outgrowth and filopodial projections in vitro, I hypothesized that myo10 is 
required for spinal motor axon growth cone guidance in vivo. Therefore, I 
used the spinal motor axons in the trunk of the zebrafish as a model to investigate the 
molecular mechanisms of myo10 in the development of the zebrafish nervous system. 
Using both morpholino oligonucleotide (MO) gene knock down and genetic mutants, I 
found that myo10 is required for proper development of both the spinal motor axons. 
Myo10 deficient embryos have truncated caudal primary (CaP) and truncated or 
missing middle primary (MiP) spinal motor axons. Because I demonstrated that myo10 
is required for spinal motor axon growth I questioned if spinal motor axon 
defects resulted in muscle atrophy. I observed mispatterning of acetylcholine 
receptors that are found in neuromuscular junctions and a decrease in myofibril width. 
These results are indicative of muscular atrophy. Lastly, I asked where myo10 could 
be functioning. Using both morpholino oligonucleotide (MO) gene knock down and 
genetic mutants I found that neural crest cell migration is partially arrested in the 
neural tube leading to less neural crest cells migrating. This provides evidence that 
myop10 is functioning within the neural crest cells. If motor axon migration is 
dependent upon proper neural crest cell migration, then the faulty neural crest cell 
migration due to myo10 deficiencies could indirectly result in axon guidance defects. 
Additionally, I used synthetic myo10 mRNA to overexpress myo10. This yielded an 
increased number of protrusions along the CaP motor axon compared to controls. This 
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provides evidence that myo10 is functioning within the axons. I also observed defects in 
other areas where myo10 is expressed.  Commissural axons in the hindbrain do not 
form as a result of the myo1o defect suggesting that myo10 is specific to its expression 
pattern. 
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CHAPTER 2 
THE BIOLOGY 
2.1: Early Neural Development 
 In the early stages of vertebrate 
development, a series of rapid mitotic events 
results in a sheet of cells located on the dorsal 
part of the embryo that will form the 
components of the nervous system (Schmidt et 
al. 2013). This region is called the 
neuroectoderm. Within the neuroectoderm, a 
region of cells express certain genes that agonize 
the formation of the neural plate (Schmidt et al. 
2013). Figure 2 chronologically demonstrates 
how the outer edges of this plate move toward 
one another to create an invagination 
(Nandadasa, et al. 2009) that ultimately 
continues until the outer edges come together 
and pinch off to form a tube-like structure that 
runs rostocaudally through the embryo and migrates away from the remaining dorsal 
ectoderm. This tube-like structure is known as the neural tube; it is the predecessor to 
the brain and spinal cord. As embryogenesis continues, cells within the neural tube 
generate axons that extend away from the neural tube. These axons will synapse with 
target cells.  
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In addition to axon formation and 
elongation at the neutral tube, another 
population of cells migrates away from the 
neural tube. These cells are known as neural 
crest cells (NCC). Neural crest cells are migratory 
cells that differentiate into several cell types that 
serve various functions depending on the 
location that they ultimately migrate to. Figure 3 
shows the four domains that neural crest cells 
can be classified into: the cranial, trunk, cardiac, 
and the vagal/sacral neural crest cells (Mayor 
and Theveneau, 2013). Each neural crest cell 
type has a different function. The trunk neural 
crest cells that are highlighted in yellow in Figure 
3 will go on to form the dorsal root ganglia for 
sensory neurons. During their migration, these 
neural crest cells are segmentally organized into 
streams (Banerjee, S et al. 2012). Interestingly, is has been demonstrated in frog that 
these neural crest cells migrate in a synchronous manner with axon migration (Banerjee, 
S et al. 2011). 
2.2: Neural Circuitry and Specification of Axons in the Trunk 
As mentioned before, the cell body of each neuron is located in the spinal cord 
while a long extention called the axon migrates to a collection of target cells. There are 
two main types of axons: primary and secondary axons. The proteins responsible for 
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axon specifiication in the 
nerual tube are Sonic 
Hedgehog (shh) and Bone 
Morphogenic Proteins 
(BMPs).  Shh and BMPs are 
morphogens that pattern 
tissue development  (Avilés et 
al. 2013). Figure 4 A and B 
shows that Shh is secreted 
from a ventrally located 
mesodermal structure called 
the notochord and migrates to 
the floor plate in the ventral portion of the neural tube while the ectoderm secretes 
BMPs that migrate into the roof plate in the most dorsal section of the neural tube 
(Charron and Tessier-Lavigne, 2007). BMP-dependent down-regulation of Shh causes 
result in the reciprocal 
concentration gradients of shh 
and BMPs (Bastida et al. 
2009). Figure 4 C and D shows 
that these two concentration 
gradients within the neural 
tube cause specification of 
neurons. With the specific 
concentration of shh in the region of the neural tube labeled in Figure 4 D “motor 
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neurons”, neurons become primary motor neurons. The remaining concentrations of 
shh and BMPs result in various other secondary neurons such as interneurons and 
sensory neurons. All of these neurons work together to complete a neural circuit. Figure 
5 models a neural circuit that powers muscle movement. A neural circuit consists of a 
sensory neuron, an interneuron, and one or more primary motor neurons. Activation of 
a neural circuit results in excitement within the neuromuscular junction to perform an 
appropriate action based on the initial sensory signal (Eisen, 1991). The primary motor 
neurons in each of these neuromuscular circuits have the largest cell bodies, thicker 
axons, and exit the spinal cord very early (Bernhardt et al. 1990) in comparison to the 
remaining classes of neurons. Because of this, they are more easily examined and 
manipulated during experimentation and therefore were used for the duration of this 
study.  
2.3: Primary Motor Axon Development and Morphology 
The trunk of the zebrafish is 
divided into segments called 
myotomes. Figure 6 depicts the 
segmentation pattern of the myotomes 
and also shows that each myotome 
contains a set of three motor neuron 
cell bodies; the rostral primary, 
middle primary, and caudal primary 
cell bodies. The cell bodies generate a 
long protrusion called an axon 
(Hirokawa et al. 2010). This axon has a dynamic structure at the most distal tip called 
16 
 
the growth cone (Bashaw and Klein, 2010). The growth cone is an extremely dynamic 
structure that contains a cytoskeletal network of microtubules along its shaft with a 
more distal population of microtubules that have not yet been stabilized (Dent et al. 
2011). These unstable microtubules are encapsulated by the lamellipodia of the growth 
cone as well as the finger-like projections of the lamellipodia called filopodia. The 
lamelliapodia and filopodia are actin rich and are controlled by constant actin 
polymerization and degradation (Betz 
et al. 2009) that is dependent upon 
molecular cues in its periphery 
resulting in a reorganization of its 
cytoskeletal microtubules and thereby 
allowing for targeted growth (Roche et 
al. 2009). This process essentially 
“steers” the growth cone in the 
appropriate direction to guide the 
axon to its predetermined target. 
According to Ananthakrishnan and 
Ehrlicher (2007), neural outgrowth is 
carried out in three cyclical steps. 
Figure 7 gives a demonstration of this 
process. First, filopodia extend to explore the extracellular matrix (ECM) in search of 
molecular cues (A). In response to the detection of axon guidance molecules in the ECM, 
a new focal contact forms with the help of cell adhesion molecules that bind the new 
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filopodia to the extracellular substrate (B). The tail end of the cell will then release its 
trailing edge adhesive contact (C) and complex contractile forces then cause the trailing 
edge of the cell to move in the wake of the leading edge (D). Using this process, the three 
primary motor axons in each segment follow specific trajectories in an independently 
manor to extend to the first intermediate target seen in Figure 8 and then migrate in 
different directions; even when confronted identical environments (Pike and Eisen, 
1990). The axons are named based on the direction that they project and their order of 
emergence. The CaP motor axon emerges from the spinal cord first and projects 
ventrally. The MiP motor axon emerges and projects dorsally. Lastly, the rostral primary 
motor neuron (RoP) emerges and projects laterally (Pike and Eisen, 1990).  Axons often 
times must travel extremely long 
distances without error. Ablation 
experiments have demonstrated 
that this feat is simplified by 
breaking axon trajectories in to 
segments. As axons travel, there are 
“check points” where specialized 
cells ensure proper growth cone 
migration. These cells also present 
additional guidance information to 
initiate growth in the appropriate 
direction that will lead them in the direction of the next checkpoint until they synapse 
with their target. (Tessier-Lavigne and Goodman, 1996). This process has proven to be 
very complex; requiring a multitude of guidance molecules to work in a precise spatial 
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and temporal fashion in order to achieve proper neurulation throughout an organism. 
Previous studies have elucidated several molecules to be involved in this process. 
2.4: Axon Development: Molecules 
As axons leave the spinal 
column and migrate to synapse their 
target cells, their sense of direction is 
obtained from molecular cues within 
the environment. The molecules 
contribute to axon guidance by 
interacting with the growth cone and 
can be categorized into two main 
groups; those that act on axons from a 
great distance (chemo group) and those that acts on axons from a short range (contact 
group). Each of these two groups is further subdivided into two additional groups; cues 
that attract and cues that repel (Tessier-Lavigne and Goodman, 1996). All in all, this 
divides molecules into four total groups; the chemo-attractants, chemo-repellants, 
contact attractants, and contact repellants (See Figure 9). The trajectories of each axon 
are believed to be dependent upon the simultaneous responses of a growth cone to all 
four types of molecular cues where long range cues act to guide the axon in a general 
direction and short range cues work to hone in on precise axon migration (Tessier-
Lavigne and Goodman, 1996). Each axon in a developing embryo responds to molecular 
cues in the environment differently depending on the variable presence of receptors 
found on each growth cone (Winckler and Mellman, 2010) in conjunction with the 
extrinsic cues generated using mechanisms such as localized protein synthesis (Jung et 
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al. 2013). All in all, these molecular cues coupled with receptors in a way “steer” the 
growth cone by promoting the initiation, extension, stabilization, or retraction of 
individual filopodia in specific regions of the growth cone (Dent et al. 2011). During the 
1990s, several molecular cues and receptors were found to contribute to axon guidance 
in vivo (Dickson, 2002). Since then, a huge effort has been put forth to create a full view 
of the molecular mechanisms of axon development. While there is a noteworthy amount 
of information known about external molecular cues in the extracellular matrix, the 
amount known about molecules within the axons that drive axon guidance is lacking. It 
has been convincingly demonstrated that myosin 2 (myo2) plays a role in axon guidance 
by controlling F-actin polymerization and retrograde flow within the axons (Lowery and 
Vactor, 2009). However, it is highly unlikely that myo2 is the only axon guidance 
molecule that functions within the axons because this would not permit compensation if 
there was a defect in the myo2 protein. Instead, it is a common phenomenon in living 
systems for multiple proteins to have functional redundancy. Functional redundancy 
allots a system multiple mechanisms to control a specific process. It is therefore likely 
that there are other contributors in the signaling pathways of axon guidance. Such 
contributors are most likely other molecules that can associate with actin (Dent et al. 
2011) and regulate the retrograde flow of actin filaments (Dickson, 2002). 
2.5: Myo10 and Axon Guidance 
Myosins are divided into two types; conventional myosins (myo2/muscle 
myosins) and unconventional myosins; which are further subdivided into several other 
classes (Hasson et al. 1996). Recently, a novel unconventional myosin, myo10, has 
gained attention in our search for novel players in axon guidance. Figure 10 shows the 
hypothesized structure and molecular mechanism of the myosin 10 protein. 
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Structurally, all myosins contain three main domains; a head domain, a neck domain, 
and a tail domain.  The head domain of myo10 binds to actin while hydrolyzing ATP to 
produce force. Myo10’s neck domain 
functions in determining the progression of 
movement along actin filaments. Finally, 
the tail contains several subdomains that 
allows for dimerization, cargo carrying, and 
microtubule binding.  With this structure, it 
is believed that myo10 dimers “walk” along actin filaments in a processive, hand over 
hand fashion where each myosin head alternates the lead progressing along actin 
filaments at about 34 nm per “step” (Qing Lu et al. 2011).  
Preliminary data in Figure 11 shows that myo10 is concentrated in the dorsal part 
of the spinal cord at 18 hours post fertilization (hpf) and is continuously present in 
migrating axons through at least 30 hpf in zebrafish. Myo2, which has already been 
established as an axon guidance molecule has a similar expression pattern; where it is 
concentrated in the central nervous system during early embryonic development and 
expands to other organs as embryogenesis continues (Huang et al. 2013).  
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There are several possible mechanisms in which myo10 deficiencies could cause 
axon guidance defects. Myo10 could reside within the axons acting as a molecule 
involved in actin polymerization or microtubule stabilization. Also possible is that 
myo10 plays a role in neural crest cell migration that ultimately causes a secondary 
effect on axon guidance. Here I used zebrafish as a model organism to study the roles 
that myo10 plays in axon guidance. 
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Chapter 3 
MATERIALS AND METHODS 
3.1: Fish Lines and Embryo Collection 
Adult zebrafish were all maintained or raised in a laboratory system following the 
published methods of Westerfield, 2007. The stages of development throughout this 
project were denoted in hours or days post fertilization according to a published staging 
series (Kimmel et al., 1995). An IUCAC proposal was submitted and approved for all 
research done in our lab using live zebrafish. I received all zebrafish from the Zebrafish 
Mutation Project. While most of the experiments done were on “wildtype” non-
transgenic zebrafish, I also used the following transgenic lines: Ptf1a, mnx-1, and isl1. 
Transgenic Mnx-1 [Tg(mnx-1:GFP)] uses the mnx-1 promoter to drive the production of 
the Green Fluorescent Protein (GFP) within the cells that produce mnx-1 proteins; 
mainly the primary motor neurons. Thus, Tg(mnx-1:GFP) zebrafish will fluoresce motor 
neurons in green. Tg(Ptf1a:GFP) expresses GFP in the pancreas and cerebellum. 
 Tg(isl1:GFP) drives GFP expression in cranial motor neurons. During the 
immunohistochemistry antibody labeling protocol, fish were fixed in 4% 
paraformaldehyde. This process washes away the green fluorescent protein. Therefore, 
virtually any transgenic line can be used for antibody labeling as long as the transgenic 
GFP is removed. 
Adult fish were removed from their living quarters and placed into smaller 
breeding tanks overnight. The males and females were separated by a plastic screen 
until approximately 9:00 am. Once the males and females were allowed to socialize 
amongst each other and the fertilization process ensued, embryos were collected and 
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placed in a petri dish with E3 zebrafish medium and stored in an incubator (28ºC). All 
embryos had their medium replaced twice daily for the extent of the experiment to 
prevent toxicity buildup and death. In order to enhance visibility, all embryos were 
exposed to 50µl of 1-phenyl 2-thiourea (PTU, 0.003% final concentration) per petri dish 
at approximately 16 hpf to prevent pigmentation. Once the embryos reached the 
appropriate age for the particular experiment, they were dechorionated, fixed in 4% 
paraformaldehyde, and sored at 4º C. 
3.2: Obtaining Morphants and Mutants 
Axon development was characterized by comparing control zebrafish larvae to 
myo10 morphants or genetic mutants. In order to create myo10 morphants I utilized a 
MO based knockdown. MOs are laboratory synthesized RNAs that are typically around 
25 base pairs long and are created to selectively attach to the mRNA of a gene of interest 
based on the rules of complementation (Bill, B. et al 2009). Additionally, MOs contain 
non-ionic phosphorodiamidate inter-subunit linkages that replace the traditional 
anionic phosphodiester linkages found in RNA backbone eliminating the negative 
charge. Taken together, the addition of a complementary strand of nucleotides to the 
target mRNA creates a physical barrier that does not allow for the association of the 
mRNA with ribosomes while the neutral charge prevents association with nucleic acid 
binding protein. This provides a stable RNA structure with resistance to nucleases while 
still resembling natural nucleic acids (Summerton and Weller, 1997). In zebrafish, MOs 
are injected into the yolk of the embryos at the 1-8 cell stage to prevent disruption of the 
early blastomere(s). These blastomeres contain cytoplasmic bridges between them that 
allow for rapid diffusion of the MO throughout all of the cells (Bill, B. et al 2009).  
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To further corroborate the findings, I also utilized genetic mutants in 
experimentation. These genetic mutants were obtained from the Zebrafish Mutation 
Project. The Zebrafish Mutation Project subjects normal zebrafish to N-ethyl-N-
nitrosourea (ENU) exposure (Kettleborough et al. 2013). ENU is a mutagen that causes 
random point mutations within the genomic DNA. ENU exposed sperm were collected 
and used to fertilize eggs generating heterozygous zebrafish. Because most of the 
zebrafish genome follows basic Mendelian Inheritance laws, crossing these 
heterozygotes with wildtype fish yields approximately 25% of the offspring that are 
homozygous for the mutation. The DNA of these fish were sequenced to identify where 
the mutation is. The zebrafish strain used in this project was sa728ix which has a 
nonsense point mutation within the myo10 gene. Once a point mutation was confirmed 
within the gene responsible for the myo10 protein, offspring from the companies known 
heterozygotes were bought. The offspring consisted of a mixture of wildtype, 
heterozygous and mutant individuals. Once fully mature, they were crossed amongst 
each other. Observing the ratios of their offspring that had mutant phenotypes allowed 
me to identify which fish were heterozygotes. If approximately 20% of the embryos had 
morphant morphology, the parents were identified as heterozygotes. The whole embryo 
morphology used to detect genetic mutants is a dorsal curvature of the trunk.   
3.3: Microinjections 
Microinjections allow substances such as solutions, MOs, or extra-organismal 
cells to be introduced into a developing embryo. Embryos were collected using a mesh 
net. Some of these embryos were put aside during each experiment to serve as non-
injected controls. The remaining embryos were microinjected with either myo10 MO 
(Gene Tools Llc.), a control MO (Gene Tools Llc.), or co-injected with myo10 MO and 
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synthetic myo10 mRNA (Ensembl ID:  ENSDART00000113347) at the 1-2 cell stage. 
The myo10 MO and control MO sequence is 5’CCTCTGCGAAGAAGGTCTCCATCTT3’ 
and 5' CCTCTTACCTCAGTTACAATTTATA-3' respectively. The synthetic myo10 mRNA 
was synthesized and cloned into the pcs2+ vector by Genscript. Glass needles for 
injections were made using a 3.5” Drummond replacement tubes (#3-000-203-g/x) in a 
Model P-1000 Fleming/Brown Micropipette Puller. These needles were filled with 5 
microliters of myo10 MO diluted in phenol red and nuclease free water to generate a 
final, optimized concentration of 2 µg/µl. Once the myo10 MO solution was in the 
needle, the needle was filled the remainder of its length with oil to eliminate any air.  A 
small pair of micro tweezers were used to break the tip of the needle and allow passage 
of the myo10 MO solution. To inject the myo10 MO into the embryos, I used a Nanoject 
II™ Auto-Nanoliter Injector. Approximately 4.6 nanoliters of the myo10 MO solution 
was injected into the yolk of each experimental embryo resulting in 9.2 ng of myo10 
MO. Rescue experiments were performed by co-injecting both myo10 MO and synthetic 
myo10 RNA at the 1-2 cell stage. When embryos reached the appropriate age for each 
experiment, they were manually dechorionated and fixed in 4% paraformaldehyde and 
stored at 4º Celsius.  
3.4: Immunohistochemistry 
Znp-1, sox-10, F59, zn-8, and alpha-bungarotoxin (α-Btx) staining are common 
techniques applied throughout this experiment. All of these are antibodies with the 
exception of α-Btx which is a toxin derived from snake venom conjugated to alexa fluor 
647 and purchased from Life Technologies. The alexa fluor conjugate has a fluorescent 
tag that enables the experimenter to visualize acetylcholine localization using 
fluorescent microscopy. All others are primary antibodies raised in either mouse or 
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rabbit. Primary antibodies are made to recognize and bind to a pre-determined antigen. 
Secondary antibodies have florescent conjugates that bind to the primary antibodies and 
thus allow for the use of florescent microscopy to view a desired tissue, structure, or 
receptor, etc… Table 1 lists each antibody and concentration used.  
Table 1. Antibodies Used for Immunohistochemistry Procedures  
Primary Antibodies Concentration 
Znp-1 
 
1:100 
Sox10 1.5:100  
F59 1:10 
Zn-8 1:10 
Secondary Antibodies Concentration 
Goat anti-mouse alexa fluor 488 2:500 
 goat-anti rabbit alexa fluor 568 2:500 
 
I stained primary motor axons using anti-synaptogamin-2 antibodies (Znp-1, 
monoclonal, mouse, Zebrafish International Resource Center (ZIRC)). Muscles were 
stained using anti-myosin heavy chain antibodies (F59, monoclonal, mouse, ZIRC), 
neural crest cells were stained using anti-sox10 antibodies (sox-10, polyclonal, rabbit, 
GeneTex), hindbrain axons were stained using anti-neurolin antibody (zn-8, 
monoclonal, mouse, ZIRC). A secondary antibody raised in goat was introduced into the 
organism that recognizes antibodies of the species that the primary antibody was 
derived from. Primary antibodies raised in mouse were exposed to goat anti-mouse 
alexa fluor 488 (Life technologies) and primary antibodies raised in rabbit were exposed 
to goat-anti rabbit alexa fluor 568. This secondary antibody has a fluorescent tag. Thus, 
fluorescing the tissue in question.  
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Embryo antibody labeling was done using the same general protocol unless 
alpha-bungaroxoin was used. Alpha-bungarotoxin stains were washed in Incubation 
Buffer (IB) overnight before continuing with the general protocol. The general protocol 
included many washes in IB. The IB recipe contained the solvents DMSO and water. 1x 
Phosphate Buffered Saline (PBS) was sued as a buffer to keep tissues at normal pH 
levels. Triton x-100 acted as a detergent to permeate the tissue. This allowed antibodies 
that were later introduced to easily saturate the tissue. The formula also contained 
bovine serum albumin and horse serum that blocked non-specific binding of antibodies. 
Details of final concentrations of reagents for IB can be found in Table 2. 
 The general protocol is as follows:  
Embryos were washed 4 times (30 minutes) in IB solution in 0.5ml tubes. After 4 
washes of IB, the embryos will be washed in an additional solution of IB containing 1% 
horse serum (500 µl IB + 5µl horse serum). The horse serum also blocks non-specific 
binding of antibodies. Afterwards, primary antibodies will be added to a solution of IB 
with 1% horse serum and allowed to incubate overnight (1:100 dilution of znp-1, 1:10 
dilution of Zn-8 and F59, and 1.5:100 dilution of sox10). If alpha-bungaroxtin was used, 
the embryo (which has already been in IB overnight) was washed with IB and horse 
serum for 30 minutes. Another was done afterwards with IB, horse serum, and a 1:500 
dilution of alpha-bungarotoxin. After 30 minutes, any additional primary antibodies 
were added and left to incubate overnight. 
The embryos received an additional set of 4 washes for 30 minutes each of IB the 
following morning. Afterwards, they were washed in a solution of IB and 1% horse 
serum and then incubated overnight in IB, horse serum, and the appropriate secondary 
antibody (2:500 dilutions). All embryos except those stained with alpha-bungarotoxin 
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were then incubated overnight in 4% paraformaldehyde/1XPBS (PFA in PBS). Alpha-
bungarotoxin stains were immediately mounted. To mount the embryos on a slide, they 
were washed 3 times in 1xPBS for 5 – 10 minutes and then moved into a 24-well plate 
and washed in a 25% solution of glycerol. Once the embryos sank to the bottom (~10 
minutes), they were washed with 50% glycerol for 10 minutes. Afterwards they will be 
placed into a 70% glycerol solution. Once in the 70% glycerol solution, individual 
embryos were placed on slides and decapitated with micro scissors. The trunk will be 
oriented laying on its side with its caudal end pointed left and rostral end pointed right. 
Small globs of Vaseline will be placed at the edges of the slide in a square pattern in such 
a way that each corner of a coverslip placed over the embryo would touch the Vaseline. 
The coverslip will then be secured by the Vaseline and the slide ready for examination. 
Table 2. Reagents and Final Concentrations for IB   
50 ml IB 
Reagent Final Concentration 
25 ml 2xPBS 1x 
23 ml dH2O -- 
500 mg Bovine Serum Albumin 1%(w/v) 
1.5 ml TritonX100 3%(v/v) 
.5 ml DMSO 1%(v/v) 
 
3.5 Software and Statistical Analysis 
 Confocal imaging was performed using ZEN 2011 or 2012 software on a LSM 710 
confocal microscope. The trunks of zebrafish were mounted laterally with anterior to the 
right and posterior end to the left.  Slides were mounted onto the microscope face down. 
This inversion caused the images to display with the anterior end to the left and 
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posterior end to the right at the time of image acquisition. Images were taken in z-
stacks; 3D. Approximately 20 slices were images per picture. All test performed were 
statistically analyzed by either a students’ T-test or G-test using JMP Pro 10 software. 
Students’ T tests were used when analyzing averages of neural crest cells. All other 
statistics performed were of percentages which were analyzed using the G-test. Each 
conclusion was drawn from a minimum of 3 experiments using myo10 MO injected 
embryos and 1 of genetic mutants unless otherwise denoted in graphs. Each experiment 
observed phenotypes from at least 5 embryos. 3 myotomes were observed per embryo 
each time. 
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Chapter 4 
RESULTS 
4.1 Myo10 is Required for Spinal Motor Axon Growth and Guidance 
4.12 Myo10 Deficiency Results in Spinal Motor Axon Defects 
In order to test roles that myo10 has on zebrafish neurodevelopment, 
morphological phenotypes of Control and myo10 deficient embryos were compared. 
Figure 12 shows a side by side comparison of each group’s trunk. The morphants 
consistently have defected trunks. Most trunks formed, but were extremely crooked 
while some did not appear to form at all. All morphants had mobility defects. Because 
zebrafish have transparent embryos, I was able to utilize antibody staining techniques to 
fluorescently label the primary motor axons in the zebrafish larvae. Figure 13 shows a 
schematic of a zebrafish embryo with an enlarged schematic of 3 myotomes of the 
zebrafish embryo. Each embryo was viewed at 40x magnification to analyze the neural 
tissue of the CaP and MiP motor axons using a confocal fluorescent microscope. I 
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observed a consistent stunt of CaP axon growth in myo10 deficient embryos. Figure 13 
displays a graphical representation of this data.  
MiP motor axons were also defective. Each embryo was viewed at either 20x or 
40x magnification to analyze the percentage of defective MiP motor axons. Figure 14 
displays a graphical representation of this data.  
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4.13 Spinal Motor Axon Defects Results in Defective Acetylcholine Receptor Patterning 
Because the spinal motor axons of myo10 deficient embryos do not extend as far 
as controls, I speculated that the spinal motor axons were not able to innervate the 
muscles. Innervation of the muscle by an axon is called a neuromuscular junction. 
Within these junctions are acetylcholine receptors on the muscle cell membrane that 
bind with acetylcholine that is produced by the pre-synaptic axon. By taking advantage 
of immunolabeling the acetylcholine receptors with α-btx in conjunction with the spinal 
motor axons with znp-1, I was able to view both the pre- and post-synaptic complexes of 
the neuromuscular junction. I hypothesized that the acetylcholine receptors would form 
normally while the axons would be truncated. Thus, revealing that the spinal motor 
axons would in fact be unable to make the connections in the distant neuromuscular 
junctions. However, as demonstrated in Figure 15, acetylcholine receptors remained 
closely co-localized with the spinal motor axons and did not extend into the muscle past 
the locations occupied by the spinal motor axons. Moreover, the acetylcholine receptors 
in myo10 deficient were disorganized when compared to the controls; instead of a 
streamline flow of acetylcholine receptors, the acetylcholine receptors appeared blotchy. 
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4.14 Axon Defects Results in Muscle Defects 
To further explore the possible roles 
that myo10 plays in axon growth and 
guidance, I investigated the points of 
innervation for the spinal motor axons; the 
muscles. Muscles are derived from 
segmented paraxial mesoderm (Bassett and 
Currie, 2003) which in turn give rise to the 
myotomes. Once the muscles are formed, 
there are two different classes of muscle 
fibers; slow muscles and fast fibers. The two muscles types are topographically separable 
in the embryonic myotome as demonstrated in Figure 16. Slow muscles are located 
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superficially and the fast muscles are located more medially within the embryo (Bassett 
and Currie, 2004). Figure 17 displays slow muscle fibers using f59 antibodies (green) 
and the acetylcholine receptors using alpha-bungarotoxin in red. Figure 17 explains that 
all groups have an equal number of slow muscle fibers per myotome. However, 
morphant individuals have a significantly decreased slow muscle fiber width. 
Calculations were made by measuring the width of four myofibrils per myotome. Two 
were measured immediately above and below the horizontal myoseptum pictured in 
yellow as “muscle pioneer” cells in Figure 16.  
4.15 Myo10 Defects Cause Axon Defects in the Hindbrain 
In order to determine the specificity of myo10 defect, I examined the 
commissural axons in the hindbrain. Commissural axons normally form and decussate 
at rhombomere boundaries (Riley et al. 2004) in the hindbrain. Myo10 expression has 
been recorded at varying levels in rhombomeres 2–5 at 18hpf. Myo10 expression 
continues in the hindbrain at 30hpf in the sensory ganglia and growing motor axons 
(Sittaramane and Chandrasekhar, 2008). Figure 18 demonstrates control, myo10 MO-
injected, and overexpressed 36hpf zebrafish hindbrains with zn-8 antibodies to observe 
the commissural axons. I saw that control and myo10 overexpressed embryos form 
commissural axons normally; while the morphant individual’s commissural axons fail to 
form at all. Because there are defects in both the hindbrain axons and the spinal motor 
axons where myo10 expression has been recorded previously, it is likely that myo10 
defects are specific to its expression pattern.  
36 
 
4.2 Mechanisms Underlying the Role of Myo10 
I have demonstrated that axon migration if affected by deficiencies of myo10 in 
the spinal motor axons in the trunk and commissural hindbrain. However, the 
underlying mechanisms of how myo10 function in this process are still obscure. The 
first step to understanding how myo10 is functioning is to determine where it is 
functioning. Based on previously shown expression patterns (Sittaramane and 
Chandrasekhar, 2008), myo10 is likely functioning within the axons themselves. 
Another possibility is that myo10 is functioning within neural crest cells. Neural crest 
cell in the trunk delaminate from the spinal cord and migrate ventrally in segmentally 
constricted lines that migrate in a synchronous manner with spinal motor axons 
(Banerjee et al. 2013). It is possible that proper axon migration is dependent upon 
proper neural crest cell migration. If this is true, faulty neural crest cell migration due to 
myo10 deficiencies would cause a domino effect on spinal motor axons. A final 
possibility is that myo10 is functioning within both neural crest cells and spinal motor 
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axons and that proper migration of the two cell types are caused by interactions between 
one another.  
4.21 Myo10 Plays a Role in Neural Crest Cell Migration 
Myo10 has been demonstrated to be required for cranial and trunk neural crest 
cell migration in Xenopus laevis (Hwang et al. 2009). Disrupting myo10 expression 
yields faulty neural crest migration where neural crest cells migrate shorter distances 
than normal embryos and also fail to migrate in the distinct streams seen in each 
hemisegment of the zebrafish embryo (Nie et al. 2009). While there previously was no 
demonstration of this data in vivo of the zebrafish trunk yet, other experiments in our 
lab have shown that neural crest cells are required for cranial neural crest cell migration 
in zebrafish. Preliminary data shown in Figure 19 provides evidence that myo10 is also 
required for neural crest cell migration in the trunk. Control and morphant embryos 
were stained in green for spinal motor axons and in red for neural crest cell. To 
determine if there were neural crest migration defects, the bottom of the spinal cord was 
labeled with a dashed white line. Each neural crest cell above that line was categorized 
as “dorsal” and each neural crest cell below the white line was categorized as “ventral”. 
The number of the neural crest cells in each category was counted manually by viewing 
slice by slice of a z-stack in zen2012 software. The averages neural crest cell distribution 
was quantified and compared between controls and mutants. The average number of 
dorsal neural crest cells were significantly higher in mutant embryos than controls (P = 
0.034978).  
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4.22 Exogenous Myo10 Increases CaP Motor Axon Protrusions 
Inducing gene overexpression involves exposing an embryo to exogenous mRNA.  
While gene knockdown is a widely utilized tool to characterize mutations and study 
molecular mechanisms, gene overexpression is another powerful tool to identify 
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phenotypes and pathways that may have been missed in a typical loss-of-function 
analysis (Prelich, 2012).  Just like gene knock-down, overexpression of a gene in an 
otherwise wild-type embryo can also cause mutant phenotypes. Figure 20 shows a 
comparison of control and overexpressed axon and acetylcholine phenotypes. I did not 
detect defects of the CaP or MiP motor axons, nor did the acetylcholine receptors appear 
disorganized. However, I did detect an increased number of protrusions in 
overexpressed axons. Figure 21 shows a comparison of control and overexpressed spinal 
motor axons in the 15th -17th myotome of the zebrafish trunk. Arrowheads were placed to 
show protrusions in CaP motor axons located on the axon in the center of each picture. 
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A dashed line was placed underneath the highest intensity, and large mass of neural 
tissue immediately exiting the spinal cord. Because znp-1 does not differentiate between 
the three primary motor axon types, this ensures that protrusions counted are only 
coming from the CaP motor axon.  
4.23 Exogenous Myo10 Partially Rescues Morphants 
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MO experiments involve creating a complementary piece of RNA that will 
successfully hybridize to target mRNA to create a barrier to prevent protein production. 
It is possible that a MO could generate by-products that could have deleterious effects 
on development. It is also possible that the MO could be hybridizing to unspecific 
targets and thus generating a domino effect that could lead to secondary phenotypes not 
caused directly by a lack of myo10. In order to analyse the effectiveness of my MO 
experiments, I co-injected synthetic myo10 RNA with myo10 MO and observed the 
characteristics of the axons, acetylcholine receptors, and the neural crest cells as 
described previously. Figure 22 shows the axons in green in the first column, the 
acetylcholine receptors in red in the second column, and merged images of both the red 
and green in the last column. As seen in the first row, the control produces normal axon 
and acetylcholine phenotypes. The second row displays phenotypes associated with the 
myo10 mutation. The third row are images of zebrafish embryos that were co-injected 
with the myo10 MO and the synthetic myo10 RNA. When compared to the control, the 
myo10 injected morphants have stunted axon growth in approximately 90% of observed 
axons as shown in Figure 22. The extent of the growth defect varied from severely 
stunted in such a way that the dorsal curvature seen at the bottom of CaP motor axons 
was completely missing while some defected CaP axons maintained a portion of this 
curvature. In order to standardize the data for the purposes of determining the ability of 
myo10 to be rescued, I defined a rescued axon to have the dorsal extension that is often 
missing in morphant CaP motor axons. Individuals displaying defective CaP motor 
axons consequently also suffer from a severe growth and patterning defect of 
acetylcholine receptors. Also, MiP motor axons extending dorsally over the spinal cord 
are also often missing in myo10 deficient embryos. Figure 22 demonstrates that rescued 
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individuals can regain dorsal curvature of the CaP axon and acetylcholine receptors and 
an increase in the number of present MiP motor axons. 
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CHAPTER 5 
DISCUSSION 
Cell culture data has supplied us with a plethora of information about axon 
guidance including the four main classes of axon guidance molecules (ephrins, slits, 
semaphorins, and netrins), their receptors, and their effect on steering the growth cone. 
Typically, ephrins, slits, and semaphorins are associated with growth cone repulsion, 
while netrins are associated primarily with attraction (Yu and Bargmann, 2001). While 
it has also been demonstrated that these molecules can be multi-functional (involved in 
both attraction and repulsion), I will focus on their typical roles of axon guidance. 
ephrins bind to eph receptors. In response, the rho family guanine nucleotide exchange 
factor (GEF), vav2, is recruited. This allows for endocytosis of ephA resulting in growth 
cone collapse and repulsion (Bashaw and Klein, 2010). Slits bind to robo receptors 
resulting in growth cone repulsion at the midline to prevent ipsilateral axons from 
crossing the midline and commissural axons from re-crossing (Dickson et al. 2002). 
Semaphorins are a very large family of axon guidance molecules that fall into 8 classes 
and bind to multimeric receptor complexes that result in growth cone repulsion when 
activated (Dickson et al. 2002) and some have been shown to be involved in motor axon 
growth and guidance (Huber et al. 2006). Netrins bind to Deleted in Colorectal Cancer 
(DCC) homodimers, which leads to growth cone attraction by increasing the number of 
filopodia and surface area of the growth cone (Huber et al. 2003). While these 
extracellular axon guidance molecules have been extensively studied, little is known 
about axon pathfinding due to intracellular molecules. Because growth cones of neurons 
are actin rich, it is likely that intracellular molecules involved in axon guidance are actin 
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binding molecules. Myosins are the only known actin-based motor proteins that are 
associated in cell motility and therefore are a likely candidate in the regulation of axon 
growth during development (Hartman and Spudich 2012). Most experimentation 
regarding myo10 to date has been performed in vitro. While in vitro experimentation 
has given us some insight on how myo10 functions. Its function will not be fully 
understood until its mechanisms can be described in the absence of the estimated 
factors used in in vitro studies.  In vivo experimentation offers further understanding of 
an experiment on a living system whose molecular dynamics drastically change during 
embryogenesis. My in vivo data has demonstrated that myo10 is required for proper 
spinal motor and hindbrain axon growth and guidance. Myo2 is a similarly structured 
molecule in the same superfamily as myo10 (Brown and Bridgman, 2003). Myo2 has 
previously been shown to play a role in axon guidance from within the axon. In recent 
studies, evidence has shown that myo2 is primarily associated with generation of 
retrograde flow of actin and contractile forces associates with cell migration in which 
myo2 possibly results in “dragging” that poster portion of the growth cone towards the 
direction of growth (Bridgman et al. 2001). It has been demonstrated that axonal 
elongation will still occur in the presence of actin polymerizing inhibitors and myo2. 
However, without actin dynamics, axonal elongation is slow and unresponsive to 
extrinsic cues (Gomez and Letourneau, 2014).  Similarly, inhibition of myo10 still 
allowed axon elongating but growth was truncated and misguided. Because similar 
results are observed in knock outs of myo10, it is likely that the myo10 axon phenotype 
is the result of a defect in myo10’s association with actin. 
Myo10 is an actin binding molecule that is expressed in both the growth cones of 
projecting axons and the neural crest cells. Interestingly, others have demonstrated that 
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defects in neural crest cells yields faulty axon growth. Thus, I speculate that it is possible 
that myo10 may be functioning within the growth cone of neurons and/or the neural 
crest cells.  
5.1 Myo10 Could be Functioning within the Growth Cone 
Experiments demonstrating expression patterns of myo10 were performed by 
Nie et al. (2009) in vitro showing that myo10 localizes to axon growth cone filopodial 
tips in vitro. Another study performed by Yu et al. 2012 used plated rat hippocampal 
neurons to show that myo10 shows preferential accumulation of myo10 to the filopodial 
tips of axon growth cones. The same study also demonstrated that down regulation of 
myo10 using mRNA yielded smaller growth cones, less filopodial extensions, a decrease 
in the longest length of neurite outgrowths, and less axon formation (Yu et al. 2012). 
These results coincide with my in vivo data that shows that both CaP and MiP axons are 
affected as a results of deficiencies of myo10. In Cap Motor axons I saw a consistent 
truncation of axon growth and MiP motor axons were often missing completely. 
Additionally, over-expression of myo10 has been reported to induce filopodial 
protrusions and to regulate growth cone motility in vitro (Watanabe et al. 2010).  My 
results indicate that increasing the expression of myo10 displays no defect in the 
zebrafish trunk in regards to truncation of CaP motor axons or missing MiP motor 
axons which are both phenotypes seen in the gene knockdown. However, wild-type 
embryos exposed to exogenous myo10 mRNA have an increased number of protrusions 
along the CaP motor axons. Because exogenous myo10 mRNA caused an increase in 
filopodial protrusions in vitro, I speculate that the increase in axon protrusions in vivo 
is also caused by an increase in filopodial protrusions during axon growth.  
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Because myo10 in the growth cone 
filopdia are actin-binding motor proteins, it is 
likely that myo10 affects axon elongation and 
guidance through altering actin dynamics. This 
occurs as demonstrated in Figure 24 due to actin 
polymerization that takes place at the leading 
edge of actin filaments at their plus (barbed) end 
(Mitchison and Cramer, 1996). During Neural 
outgrowth, actin-rich filopodia first extend to 
explore the extracellular matrix (ECM) in search 
of molecular cues in the extracellular matrix. 
These cues associate with receptors location on the cell membrane of the growth cone. 
For example, the axon guidance molecule netrin-1 binds to DCC receptors on the growth 
cone. This causes a cascade of events that ultimately phosphorylates and activates 
Ena/Vasp proteins (Lebrand et al. 2004). Interestingly, it has been demonstrated that 
47 
 
Vasp proteins are a cargo of myo1o. Myo10 is believed to be invovled in actin 
polymerization by utilizing its actin binding motor to “walk” down F-actin fiaments in a 
step like fasion where it transports cargos (Ricca and Rock, 2010). Hypothesized 
molecular structures suggests that myo10 dimerizes to form a molecule whose head 
domains binds to actin and “walk” along actin filaments at the filopodial tips in a hand-
over-hand processive fashion (Ricca and Rock, 2010). In order to activate myo10’s 
capacity to utilize its motor to transport, phosphoinositol PI3-kinase (PI3K) is activated 
within the filopodia. These kinases generate PtdIns that recruit myo10 (Isakoff 1998). 
PtdIns are membrane-anchored lipids that serve as docking sites for many pleckstrin 
homology domain-containing proteins. Myo10 contains a PH domain within its tail that 
can bind ptdIns which enhances myo10 localization to the filopodia and promotes is 
motor activity (Arjonen et al. 2011, Plantard 2010 and Yu at al. 2012).  Once myo10 is 
localized to the filopodia, it can bind Mena/Vasp at its MyTH4/FERM domain and 
transport it to filopodial tip. This hypothesized mechanism aligns with studies that have 
deleted the cargo carrying MyTH4/FERM domains which abolished myo10’s ability to 
promote filopodial extension (Wei et al. 2010). VASP proteins inhibit protein capping of 
actin filaments that allow additional actin polymers to be adding to the bared end of the 
actin filament (See Figure 24). Myo10 has been demonstrated to transport Mena/VASP 
to the filopodial tips in cell cultures (Tokuo and Ikebe, 2004). Taken together, because 
axons deficient in myo10 in zebrafish display stunted axon growth, it is likely that 
myo10 functions in filopodial extension in vivo via transportation of Mena/VASP that is 
likely bound to the myTH4/FERM complex of myo10. Without myo10, the Mena/VASP 
will not be transported to the filopodial tip to compete with capping proteins. Without 
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removal of capping proteins, filopodial extension will not occur. Consequently, the 
inability of axon elongation results in the observed stunted axon development.  
Another possible mechanism behind filopodial growth is that myo10 transports 
other cargos such as DCC. Zhu et al. 2007 showed that myo10 transported DCC to the 
filopodial tips. This is interesting because DCC interacts with molecules involved in 
netrin signaling which promotes axon outgrowth and mediates attractive growth cone 
guidance of axon projections (Liu, 2012).  
Others have seen similar defects in morphants that have mutations in other 
genes. For example, the gene, diwanka, has been shown to control growth cone 
guidance (Zeller and Granato, 1999). In diwanka deficient zebrafish embryos, the spinal 
motor neurons in the trunk are still present, but CaP and Mip motor axons are truncated 
95% of the time to some degree. Zeller and Granato also examined hindbrain neurons in 
diwanka mutants and observed no defect. In myo10 deficient embryos, I observed the 
same truncation in the CaP and MiP axons. However, I also observed defects in 
hindbrain axons. Thus, it is likely that both gene products are involved in the same 
process but in cell populations that diwanka is not. Unplugged mutants also display 
spinal motor neuron defects in the trunk of the zebrafish. However this mutation results 
in a different defect. In unplugged mutants, CaP and RoP motor neurons have abnormal 
axon projections while MiP appears normal (Beattie, 2000). Because I saw a different 
defect, it is likely that myo10 and unplugged gene products are involved in separate 
processes. Stumpy mutants also display spinal motor axon guidance defects that cause 
elongation pausing of CaP motor axons during axon elongation (Beattie, 2000).  In 
order to determine if myo10 is required for axon elongation past intermediate targets 
like stumpy, time-lapse observations of myo10 deficient axons are necessary. Finally, 
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survival motor neuron (smn) also displays defects in the spinal motor axons 
(McWhorter et al. 2003). At low levels, motor axon branching and truncating was 
observed. At higher levels, truncation was less common and more branching occurred.  
5.2 Muscle Defects are a Result of Motor Neuron Defects 
Axon elongation and migration of primary motor axons completes when the 
growth cone reaches its target, the muscle. The combination of the axon and muscle 
forms a synapse at the neuromuscular junction. This complex is made of up the pre-
synaptic axon and the post synaptic muscle (Wu et al. 2010). The muscle membrane is 
lined with acetylcholine receptors that are produced in response to Acetylcholine 
Receptor Inducing Activity (ARIA); a glycoprotein made by motor neurons and released 
at the neuromuscular synapse to stimulate the synthesis of acetylcholine receptors by 
skeletal muscle. These receptors bind Acetylcholine which transmits signals across the 
synapse from the axon to the muscle for contraction (Wu et al. 2010). By labeling the 
acetylcholine receptors with the axons, I was able to see both the pre-synaptic and post-
synaptic ends of the complex to reveal information about neural circuitry. In the 
morphant, acetylcholine receptors were present, yet unorganized compared to the 
controls. This means that while synapses were still forming at neuromuscular junctions, 
they are not forming in the right places. Consistent with this observation, I observed 
mobility defects in morphant individuals, but not paralysis. Additionally, instead of a 
streamline flow of seemingly uniformly distributed acetylcholine receptors, the 
concentration of acetylcholine receptors of morphants appeared upregulated in the 
areas where they are present, giving them a blotchy labeling in fluorescent labeling. This 
is consistent with a study done in chick that demonstrated that muscle denervation 
activates acetylcholine receptor genes (Tsay and Schmidt, 1989). Because issues with 
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synapses often lead to muscle defects in neurodegenerative diseases, I examined the 
muscles. I observed the slow muscle bands and did not see a difference in band numbers 
across all groups (control, MO-injected, and RNA-injected). However, the thickness of 
the bands were significantly smaller in MO-injected embryos compared to controls 
(P<.0001). Others have demonstrated that denervation of the muscular tissue from the 
nervous system results in muscle fibers thickness decrease in rat indicating muscular 
atrophy (Fambrough, 1974).  Thus, the decrease in myofibril width indicates muscular 
atrophy which is likely to be a causal effect from the synaptic defects. The disorganized 
distribution of acetylcholine patterns is indicative of improper innervation of the 
muscles from the axons. In many neurodegenerative diseases such as muscular 
dystrophy and Amyotrophic Lateral Sclerosis (ALS) axons loose connectivity with the 
muscles. This lack of connectivity leads to muscle weakness and eventually degeneration 
(Fambrough, 1974). A related disease, Spinal Muscular Atrophy (SMA) has been 
associated with loss of smn protein previously mentioned (Winkler et al. 2005). In the 
previous study by McWhorter et al. 2003, they observed muscle cross sections of smn 
mutants and reported not to see any defect in the muscle. However, I observed lateral 
images of zebrafish myo10 mutants displaying similar axon phenotypes in the axons 
that were seen in smn mutants. Axon truncations observed resulted in musculature 
innervation disorganization. Because innervation is induced by the neurons themselves 
and not the muscle (Corfas, 1992), it is probably that smn mutants also have 
disorganized acetylcholine receptors. The acetylcholine receptor mispatterning indicates 
musculature innervation defects which have been shown to cause muscle band thickness 
decreases and result in the muscular atrophy seen. While this is only speculation, a 
more recent study observed muscle fiber areas in control and smn deficient rats. They 
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reported that while there was no difference in muscle fiber counts or muscle fiber area 
means, there was a difference in distribution of muscle fiber are between smn mutants 
and controls (Gavrilina et al. 2007). 
In zebrafish, there are three myo10 genes; myo10a, myo10b, and myo10c. 
Myo10a has been shown to be present in the spinal cord and developing neurons at 
18hpf along with other areas in the brain at 30hpf (Sittaramane and Chandrasekhar, 
2008). While expression patterns of myo10b and myo10c are still unknown, leaving the 
possibility that myo10 defects are due to a down regulation of myo10 functioning in the 
muscle, it is likely that muscle band width defects are a causal effect from muscle 
weakening due to innervation issues instead of a direct effect of myo10 knockdown. 
Muscle weakness is typical in patients with neuromuscular disorders such as muscular 
dystrophy and Amyotrophic Lateral Sclerosis (ALS) in humans. Interestingly, it has 
been recorded that primary motor neurons in zebrafish form synapses with fast muscle 
fibers and not slow muscle fibers. Instead, secondary motor neurons (smn) form 
synapses with the slow muscle fibers (Babin et al. 2014). Thus, myo10 deficiencies may 
also cause snm defects that are causing the slow muscle malformation. Future 
experiments should be performed that examine smn with slow myo10 deficient 
individuals as well as experiments examining the primary motor axons in conjunction 
with fast muscle tissue. 
5.3 Myo10 may be functioning in Neural Crest Cells 
In the second phase of neural outgrowth described previously, filopodia adhere to 
the substrate in response to attractive molecules via complex interactions between 
extracellular matrix proteins, cell adhesion proteins, and the actin cytoskeleton. Myo10 
has been shown to form complexes with integrins which are cell adhesion proteins that 
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bind to its FERM domain and possibly serve as a link between actin filaments and the 
extracellular (Arjonen et al. 2011 and Breshears et al. 2010). However, Hirano et al. 
claims that DCC binding of myo10 interferes with integrin binding. Because DCC bound 
to myo10 induces netrin signaling and thus axon outgrowth, it is possible that another 
molecule interacts with integrins to support adhesive contacts with the ECM or that 
DCC and integrins compete for myo10 thus allowing for both adhesion and extension 
simultaneously. Knowing that myo10 is capable of linking actin inside the filopodia to 
the outside of the cell makes is possible that this property could allow myo10 to serve as 
a link between the filopodia and the neural crest cells. It is possible that the filopodia 
essentially use the migrating neural crest cells in the vicinity as a tool to help generate 
new focal points.  
Another gene that has been associated with neural crest cell specification and 
migration is foxd3. Sym-1 mutants have a deletion that disrupts the DNA binding 
domain of the foxd3 gene. At 24hpf, control zebrafish embryos expressing sox 10 (a 
neural crest cell marker) showed normal stream-like migration patterns in the trunk 
(Stewart et al. 2005). However, sym-1 mutant sox-10 expressing cells were still on the 
dorsal neural tube. This coincides with my data in myo10 mutant individuals where sox-
10 expressing cells are present but migration appears to be arrested. Other molecules 
involved in proper neural crest cell migration are MuSK and Wnt11r. In deficient 
embryos, neural crest cells still migrate, but are not restricted to the typical organized 
streams that follow spinal motor axons in control embryos (Banerjee et al. 2011). 
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5.4 Future Directions 
While I have provided a lot of information on the morphology of myo10 deficient 
embryos, there is a lot to test to determine how myo10 functions. I observed the 
commissural axons in the hindbrain to test the specificity of myo10. These axons also 
express myo10 during development.  In the morphant, the commissural axons fail to 
migrate. So far, tissue expressing myo1o has displayed defects. This indicates that 
myo10 is likely to be specific to its expression pattern. However, further experiments 
must be done in tissues that do not express myo10. If tissues that do not express myo10 
form normally, then myo10 can be reported to function specifically. 
Because, myo10 protein is an intracellular protein and is unable to travel across 
cell membranes, I could determine if myo10 is functioning within the axons by a series 
of transplantation experiments. Transplantation techniques can be used to create 
genetic mosaic organisms known as chimeras that allow a mixture of cells of two or 
more different genotypes to be incorporated into a single organism (Carmany-Rampey, 
2006). This method enables us to analyse mutant cells in an otherwise wildtype 
environment and vice versa. Others have also used this technique to successfully 
identify the cell autonomy of other genes such as spt-1 (Ho and Kane, 1990). 
Additionally, Song et al. 2013 successfully utilized transplantation of zebrafish spinal 
motor neurons. Completing a series of transplant experiments in both neurons and 
neural crest cells will help deduce where myo10 in functioning in vivo. 
No rescue experiments of myo10 defect have previously been done. My in vivo 
gene rescue experiments shows that there is a possibility to rescue axon phenotypes by 
co-injecting myo10 MO knock down embryos with exogenous myo10 mRNA. Knock-
down embryos display severely truncated CaP motor axons in which ~74% do not 
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migrate ventrally after dorsal elongation. Co-injection of exogenous myo10 mRNA with 
the myo10 MO resulted in ~36% of axons missing the ventral curvature. While the 
rescue seemed to increase the CaP motor axons ability to elongate, axons were still not 
completely rescued. They appear to by misguided rosto-causally, while still maintaining 
the stereotypical ventral elongation followed by a dorsal curvature. Replacement of 
endogenous protein with exogenous proteins can cause a lot of problems in vivo. For 
example, introducing a large volume of exogenous material can be toxic to a developing 
embryo. This can affect the overall health of the organism and could explain the results. 
Partial rescue after co-injection of a MO with mRNA is commonly in other rescues 
(McWhorter et al. 2003 and McClintock 2002) and is probably caused by the mosaicism 
of RNA distribution. After co-injecting of myo10 MO and myo10 RNA in vivo, the 
experimenter has no control of how these particles diffuse. It is possible that exogenous 
amounts of mRNA and the MO are not equally distributed throughout the embryo.  
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